WS #10527
The data dump is dominated by sports betting (Polymarket trades), routine corporate announcements, and noise. However, several actionable signals emerge. First, Iran's President Pezeshkian stated that Iran will never negotiate its defensive ability and that missiles were not part of any MOU, reinforcing a hardline stance that could dampen hopes for a US-Iran deal and support oil prices. Second, SpaceX drew $89 billion in demand for its debut high-grade bond sale, signaling strong investor appetite for the company despite its post-IPO stock slump. Third, a report suggests Trump may be the mystery patient receiving Eli Lilly's experimental obesity drug retatrutide, which could be a positive catalyst for LLY if confirmed. Fourth, Russia is considering a full ban on diesel exports due to domestic fuel market disruptions, which would be bullish for oil refiners and bearish for airlines. Fifth, the Bank of England's Alan Taylor signaled readiness to cut rates if inflation eases, a dovish tilt for UK monetary policy. The prevailing tech selloff narrative is stable, with no new escalation or de-escalation signals in this window.
Topics
Key developments
- Iran's President: Missiles Not in MOU, Will Never Negotiate Defensive Ability
- SpaceX Draws $89 Billion Demand for Debut High-Grade Bond Sale
- Trump May Be Mystery Patient Receiving Eli Lilly's Experimental Obesity Drug
- Russia Considering Full Ban on Diesel Exports
- Bank of England Official Signals Readiness to Cut Rates